Can digoxin cause complete (third-degree) heart block?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Digoxin Cause Complete Heart Block?

Yes, digoxin can cause complete (third-degree) heart block, particularly in patients with pre-existing conduction system disease, and this represents a serious manifestation of digoxin toxicity that may require urgent intervention including temporary pacing and digoxin-specific antibody fragments.

Mechanism and Clinical Context

Digoxin slows sinoatrial and AV conduction, commonly prolonging the PR interval 1. The drug may cause severe sinus bradycardia or sinoatrial block in patients with pre-existing sinus node disease and may cause advanced or complete heart block in patients with pre-existing incomplete AV block 1.

Digoxin Toxicity Arrhythmias

Typical arrhythmias related to digoxin toxicity include enhanced atrial, junctional, or ventricular automaticity (with ectopic beats or tachycardia) often combined with atrioventricular block 2. High doses of digoxin may produce a variety of rhythm disturbances, including first-degree, second-degree (Wenckebach), or third-degree heart block (including asystole) 1.

Contraindications and Precautions

Absolute Contraindications

  • Second- or third-degree heart block (without a permanent pacemaker) 2
  • Suspected sick sinus syndrome (use with caution) 2
  • Pre-excitation syndromes 2

High-Risk Situations

AV block greater than first degree or SA node dysfunction (in absence of pacemaker) is listed as a contraindication across multiple guidelines 2. In such patients, consideration should be given to the insertion of a pacemaker before treatment with digoxin 1.

Clinical Presentation of Digoxin-Induced CHB

Recent case reports demonstrate the clinical reality of digoxin-induced complete heart block:

  • A 66-year-old male with heart failure presented in cardiogenic shock due to bradycardia resulting from third-degree AV block with varying escape rhythm (minimum of 20 bpm) with elevated digoxin levels (3.2-3.4 µg/L) 3
  • A patient on hemodialysis presented with complete heart block and heart rate of 30 bpm associated with significantly raised serum digoxin concentrations 4
  • A case of massive digoxin overdose resulted in atrio-ventricular block 3 degree among other arrhythmias 5

Management of Digoxin-Induced CHB

Immediate Interventions

  1. Temporary pacing is highly effective and may be needed for atrioventricular block or asystole 2
  2. Digoxin-specific Fab antibody fragments should be considered for serious arrhythmias such as complete heart block 2
  3. A temporary external pacemaker lead should be placed for hemodynamically significant bradycardia 3

Treatment Response

Following administration of digoxin-specific antibody fragments (digoxin-Fabs), complete recovery of AV-conduction has been observed 3. In one study, cardiotoxicity resolved in 7 of 9 evaluable patients within 24 hours after DSAb administration 6.

Important Clinical Considerations

Potentiating Factors

Digoxin toxicity and associated heart block may be potentiated by 2:

  • Hypothyroidism
  • Hypokalemia
  • Renal dysfunction

Drug Interactions

The drug should be used cautiously in patients taking other drugs that can depress sinus or atrioventricular nodal function 2, including:

  • Beta blockers 2
  • Amiodarone 2
  • Verapamil 2
  • Diltiazem 2

Therapeutic vs. Toxic Levels

Overt digoxin toxicity is commonly associated with serum digoxin levels >2 ng/mL 2. However, toxicity may also occur with lower digoxin levels, especially if hypokalemia, hypomagnesemia, or hypothyroidism coexists 2.

Contemporary Perspective on "Drug-Induced" vs. "Drug-Revealed" AVB

Recent evidence suggests that true drug-induced AVB is rare, while recurrence rates are high 7. The development of advanced AVB in patients on bradycardic therapy raises the question of whether the AVB is directly caused by these agents or if the drugs exacerbate underlying conduction system disease 7. Despite initial resolution after drug discontinuation, high recurrence rates of AVB have been documented 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.